We therefore propose that the tumor-suppressive activity of FXR might be mediated in part via activation of endogenous FXR in mouse cells, namely liver parenchymal, endothelial or even lymphoid cells (e.g. Kupffer cells), resulting in a changed microenvironment unfavourable for tumor growth or metastasis. Here, NR1H4 is linked to neoplasm.